---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-013326"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2022-05-24T23:59:59+00:00"
generated_at: "2026-06-25T07:28:45.674334+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Diffusion Pharmaceuticals appoints Raven Jaeger as Chief Regulatory Officer

## Summary
- Raven Jaeger, former SVP Regulatory Affairs at BridgeBio, named Chief Regulatory Officer effective May 18, 2022.
- She brings 20 years regulatory experience, including leading team to first FDA approval at BridgeBio.
- Compensation: $400k base salary, 35% target bonus, $60k sign-on bonus, 8,000 stock options vesting over 36 months.
- She will oversee regulatory strategy for lead candidate TSC (trans sodium crocetinate) for hypoxic solid tumors.

## SEC filing metadata
- accession: 0001437749-22-013326
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2022-05-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774922013326/0001437749-22-013326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774922013326/dffn20220523_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-013326
- JSON: https://secwatch.observer/filing/0001437749-22-013326.json
- Plain text: https://secwatch.observer/filing/0001437749-22-013326.txt

## Key facts
- Executive change
  Raven Jaeger was appointed as Chief Regulatory Officer at CervoMed Inc..
  - Action: appointed
  - Role: Chief Regulatory Officer
  source text: On May 18, 2022, Raven Jaeger, M.S., was appointed as the Chief Regulatory Officer of Diffusion Pharmaceuticals Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053691/000143774922013326/0001437749-22-013326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.